AMR: IMI’s Enable project reaches endpoints

  29 January 2020

The IMI project was recently granted a one-year extension to promote further progression of ongoing programmes, while keeping within the original budget of about €100m. ENABLE was formed in 2014 to accelerate the development of new antibiotics for the treatment of difficult-to-treat Gram-negative  infections. The project has so far identified five antibacterial leads.

Author(s): TG
Smart Innovations  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!